Zoetis Inc
ZTS156.320USD
+0.889+0.57%
Fechamento 04/30, 16:00（ET）Cotações atrasadas em 15 min
70.11BValor de mercado
28.20P/L TTM
Mais detalhes de Zoetis Inc Empresa
Zoetis Inc. is a global animal health company. The Company is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests and precision animal health. The Company operates through two segments: the United States (U.S.) and International. Within each of these operating segments, it offers a diversified product portfolio, including parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health diagnostics, for both companion animal and livestock customers. It directly markets its products in approximately 45 countries across North America, Europe, Africa, Asia, Australia and South America. The Company is engaged in commercializing products across eight species: dogs, cats and horses (collectively, companion animals) and cattle, poultry, swine, fish and sheep (collectively, livestock).
Informações da empresa
Código da empresaZTS
Nome da EmpresaZoetis Inc
Data de listagemFeb 01, 2013
Fundado em2012
CEOMs. Kristin C. Peck
Número de funcionários13800
Tipo de títulosOrdinary Share
Fim do ano fiscalFeb 01
Endereço10 Sylvan Way
CidadePARSIPPANY
Bolsa de valoresNYSE Consolidated
PaísUnited States of America
Código postal07054
Telefone19738227000
Sitehttps://www.zoetis.com/
Código da empresaZTS
Data de listagemFeb 01, 2013
Fundado em2012
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Ms. Kristin C. Peck
Ms. Kristin C. Peck
Chief Executive Officer, Director
Chief Executive Officer, Director
95.01K
+0.02%
Mr. Michael B. Mccallister
Mr. Michael B. Mccallister
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
27.69K
+155.58%
Mr. Robert W. Scully
Mr. Robert W. Scully
Independent Director
Independent Director
22.13K
--
Mr. Gregory (Greg) Norden
Mr. Gregory (Greg) Norden
Independent Director
Independent Director
16.95K
+12.20%
Ms. Louise M. Parent
Ms. Louise M. Parent
Independent Director
Independent Director
15.26K
--
Mr. Frank A. D'amelio
Mr. Frank A. D'amelio
Independent Director
Independent Director
14.81K
--
Mr. Sanjay Khosla
Mr. Sanjay Khosla
Independent Director
Independent Director
9.81K
--
Mr. Robert J. Polzer, Ph.D.
Mr. Robert J. Polzer, Ph.D.
Executive Vice President, President - Research and Development
Executive Vice President, President - Research and Development
6.19K
+0.39%
Ms. Rimma Driscoll
Ms. Rimma Driscoll
Executive Vice President and Head of Global Strategy, Commercial and Business Development, and Global BioDevices
Executive Vice President and Head of Global Strategy, Commercial and Business Development, and Global BioDevices
5.19K
+8.28%
Mr. Jamie Brannan
Mr. Jamie Brannan
Executive Vice President, Chief Commercial Officer
Executive Vice President, Chief Commercial Officer
2.59K
+19.25%
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Ms. Kristin C. Peck
Ms. Kristin C. Peck
Chief Executive Officer, Director
Chief Executive Officer, Director
95.01K
+0.02%
Mr. Michael B. Mccallister
Mr. Michael B. Mccallister
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
27.69K
+155.58%
Mr. Robert W. Scully
Mr. Robert W. Scully
Independent Director
Independent Director
22.13K
--
Mr. Gregory (Greg) Norden
Mr. Gregory (Greg) Norden
Independent Director
Independent Director
16.95K
+12.20%
Ms. Louise M. Parent
Ms. Louise M. Parent
Independent Director
Independent Director
15.26K
--
Mr. Frank A. D'amelio
Mr. Frank A. D'amelio
Independent Director
Independent Director
14.81K
--
Detalhamento da receita
Moeda: USDTempo de atualização: dom, 6 de abr
Moeda: USDTempo de atualização: dom, 6 de abr
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
Por EmpresaUSD
Nome
Receita
Proporção
Parasiticides
2.15B
23.26%
Vaccines
1.83B
19.74%
Dermatology
1.66B
17.88%
Anti-infectives
1.10B
11.88%
Pain and sedation
851.00M
9.19%
Other
1.67B
18.04%
Por RegiãoUSD
Nome
Receita
Proporção
United States
5.07B
54.82%
Other emerging markets
865.00M
9.35%
Other Developed
564.00M
6.09%
Brazil
414.00M
4.47%
Australia
319.00M
3.45%
Other
2.02B
21.82%
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Parasiticides
2.15B
23.26%
Vaccines
1.83B
19.74%
Dermatology
1.66B
17.88%
Anti-infectives
1.10B
11.88%
Pain and sedation
851.00M
9.19%
Other
1.67B
18.04%
Acionista
Tempo de atualização: sex, 21 de fev
Tempo de atualização: sex, 21 de fev
Estatísticas dos acionistas
Tipo
Estatísticas dos acionistas
Acionista
Proporção
The Vanguard Group, Inc.
9.23%
BlackRock Institutional Trust Company, N.A.
5.14%
State Street Global Advisors (US)
4.45%
State Farm Insurance Companies
3.59%
AllianceBernstein L.P.
2.65%
Other
74.94%
Estatísticas dos acionistas
Acionista
Proporção
The Vanguard Group, Inc.
9.23%
BlackRock Institutional Trust Company, N.A.
5.14%
State Street Global Advisors (US)
4.45%
State Farm Insurance Companies
3.59%
AllianceBernstein L.P.
2.65%
Other
74.94%
Tipo
Acionista
Proporção
Investment Advisor/Hedge Fund
41.13%
Investment Advisor
38.78%
Research Firm
4.78%
Insurance Company
3.73%
Pension Fund
2.51%
Bank and Trust
2.49%
Hedge Fund
1.41%
Sovereign Wealth Fund
1.23%
Corporation
0.14%
Other
3.81%
Participação acionária institucional
Tempo de atualização: dom, 19 de jan
Tempo de atualização: dom, 19 de jan
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q1
3200
431.23M
96.67%
-7.62M
2024Q4
3199
430.60M
96.14%
-9.58M
2024Q3
3090
434.14M
95.81%
-13.19M
2024Q2
3062
437.75M
95.94%
-9.33M
2024Q1
3060
439.45M
96.16%
-2.63M
2023Q4
3074
438.13M
95.43%
-2.08M
2023Q3
2966
434.04M
94.28%
-3.00M
2023Q2
2949
430.67M
93.19%
-11.77M
2023Q1
2913
436.42M
94.33%
-5.14M
2022Q4
2889
436.14M
93.57%
-8.47M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
The Vanguard Group, Inc.
41.17M
9.19%
+127.66K
+0.31%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
22.94M
5.12%
-145.06K
-0.63%
Dec 31, 2024
State Street Global Advisors (US)
19.84M
4.43%
+63.50K
+0.32%
Dec 31, 2024
State Farm Insurance Companies
16.01M
3.58%
-26.09K
-0.16%
Dec 31, 2024
AllianceBernstein L.P.
11.81M
2.64%
-3.58M
-23.26%
Dec 31, 2024
Geode Capital Management, L.L.C.
10.62M
2.37%
+190.14K
+1.82%
Dec 31, 2024
Polen Capital Management, LLC
7.48M
1.67%
+1.12M
+17.54%
Dec 31, 2024
Managed Account Advisors LLC
7.02M
1.57%
-2.23M
-24.12%
Dec 31, 2024
Wellington Management Company, LLP
6.96M
1.55%
+3.06M
+78.46%
Dec 31, 2024
Capital World Investors
6.56M
1.47%
-121.21K
-1.81%
Dec 31, 2024
Ver Mais
ETFs Relacionados
Tempo de atualização: dom, 6 de abr
Tempo de atualização: dom, 6 de abr
Nome
Proporção
ProShares Pet Care ETF
9.92%
VanEck Agribusiness ETF
7.64%
VanEck Pharmaceutical ETF
4.8%
Natixis Vaughan Nelson Select ETF
4.5%
iShares U.S. Pharmaceuticals ETF
4.38%
First Trust NASDAQ Pharmaceuticals ETF
3.85%
Honeytree US Equity ETF
3.83%
SPDR S&P Pharmaceuticals ETF
3.64%
Jensen Quality Growth ETF
3.37%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
2.55%
Ver Mais
ProShares Pet Care ETF
Proporção9.92%
VanEck Agribusiness ETF
Proporção7.64%
VanEck Pharmaceutical ETF
Proporção4.8%
Natixis Vaughan Nelson Select ETF
Proporção4.5%
iShares U.S. Pharmaceuticals ETF
Proporção4.38%
First Trust NASDAQ Pharmaceuticals ETF
Proporção3.85%
Honeytree US Equity ETF
Proporção3.83%
SPDR S&P Pharmaceuticals ETF
Proporção3.64%
Jensen Quality Growth ETF
Proporção3.37%
Direxion Daily Pharmaceutical & Medical Bl 3X ETF
Proporção2.55%
Dividendo
Um total de
2.94B
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Dec 12, 2024
ZTS.NB Interim Cash Dividend of gross USD 0.5 paid on Mar 04, 2025 going ex on Jan 21, 2025
Jan 21, 2025
Mar 04, 2025
Jan 21, 2025
Oct 10, 2024
ZTS.NB Final Cash Dividend of gross USD 0.432 paid on Dec 03, 2024 going ex on Oct 31, 2024
Oct 31, 2024
Dec 03, 2024
Oct 31, 2024
May 22, 2024
ZTS.NB Interim Cash Dividend of gross USD 0.432 paid on Sep 04, 2024 going ex on Jul 18, 2024
Jul 18, 2024
Sep 04, 2024
Jul 18, 2024
Feb 06, 2024
ZTS.NB Interim Cash Dividend of gross USD 0.432 paid on Jun 04, 2024 going ex on Apr 18, 2024
Apr 19, 2024
Jun 04, 2024
Apr 18, 2024
Dec 07, 2023
ZTS.NB Interim Cash Dividend of gross USD 0.432 paid on Mar 01, 2024 going ex on Jan 18, 2024
Jan 19, 2024
Mar 01, 2024
Jan 18, 2024
Oct 12, 2023
ZTS.NB Final Cash Dividend of gross USD 0.375 paid on Dec 01, 2023 going ex on Oct 31, 2023
Nov 01, 2023
Dec 01, 2023
Oct 31, 2023
May 11, 2023
ZTS.NB Interim Cash Dividend of gross USD 0.375 paid on Sep 01, 2023 going ex on Jul 20, 2023
Jul 21, 2023
Sep 01, 2023
Jul 20, 2023
Feb 08, 2023
ZTS.NB Interim Cash Dividend of gross USD 0.375 paid on Jun 01, 2023 going ex on Apr 20, 2023
Apr 21, 2023
Jun 01, 2023
Apr 20, 2023
Dec 08, 2022
ZTS.NB Interim Cash Dividend of gross USD 0.375 paid on Mar 01, 2023 going ex on Jan 19, 2023
Jan 20, 2023
Mar 01, 2023
Jan 19, 2023
Oct 13, 2022
ZTS.NB Final Cash Dividend of gross USD 0.325 paid on Dec 01, 2022 going ex on Oct 31, 2022
Nov 01, 2022
Dec 01, 2022
Oct 31, 2022
Ver Mais
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados